Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MRX Stock Forecast 2025-2026
$47.38
Current Price
$3.45B
Market Cap
Buy 7
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to MRX Price Targets
+5.5%
To High Target of $50.00
-6.1%
To Median Target of $44.50
-24.0%
To Low Target of $36.00
MRX Price Momentum
+5.0%
1 Week Change
+26.6%
1 Month Change
+148.8%
1 Year Change
+52.0%
Year-to-Date Change
-3.1%
From 52W High of $48.91
+161.3%
From 52W Low of $18.13
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Marex (MRX) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MRX and similar high-potential opportunities.
Latest MRX Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, MRX has a bullish consensus with a median price target of $44.50 (ranging from $36.00 to $50.00). Currently trading at $47.38, the median forecast implies a -6.1% downside. This outlook is supported by 7 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Kyle Voigt at Keefe, Bruyette & Woods, suggesting a 24.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MRX Analyst Ratings
7
Buy
1
Hold
0
Sell
MRX Price Target Range
Low
$36.00
Average
$44.50
High
$50.00
Current: $47.38
Latest MRX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MRX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $44.00 |
| Apr 3, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $44.00 |
| Mar 7, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $40.00 |
| Mar 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $43.00 |
| Jan 13, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $39.00 |
| Jan 7, 2025 | Piper Sandler | Patrick Moley | Overweight | Maintains | $40.00 |
| Dec 20, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Outperform | Maintains | $36.00 |
| Dec 9, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $35.00 |
| Nov 21, 2024 | HSBC | Carlos Gomez-Lopez | Buy | Initiates | $33.00 |
| Nov 8, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $32.00 |
| Nov 8, 2024 | Piper Sandler | Patrick Moley | Overweight | Maintains | $32.00 |
| Nov 8, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Outperform | Maintains | $33.00 |
| Nov 6, 2024 | Citigroup | Chris Allen | Buy | Reinstates | $34.00 |
| Oct 7, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $30.00 |
| Aug 15, 2024 | Piper Sandler | Patrick Moley | Overweight | Maintains | $30.00 |
| Aug 15, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $28.00 |
| Aug 14, 2024 | Piper Sandler | Patrick Moley | Overweight | Reiterates | $27.00 |
| May 20, 2024 | Citigroup | Chris Allen | Buy | Initiates | $24.00 |
| May 20, 2024 | Goldman Sachs | Alexander Blostein | Buy | Initiates | $33.00 |
| May 20, 2024 | Piper Sandler | Patrick Moley | Overweight | Initiates | $27.00 |
Marex Group plc (MRX) Competitors
The following stocks are similar to Marex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Marex Group plc (MRX) Financial Data
Marex Group plc has a market capitalization of $3.45B with a P/E ratio of 17.4x. The company generates $2.36B in trailing twelve-month revenue with a 9.3% profit margin.
Revenue growth is +22.3% quarter-over-quarter, while maintaining an operating margin of +4.7% and return on equity of +24.9%.
Valuation Metrics
Market Cap
$3.45B
Enterprise Value
$3.78B
P/E Ratio
17.4x
PEG Ratio
15.9x
Price/Sales
1.5x
Growth & Margins
Revenue Growth (YoY)
+22.3%
Gross Margin
N/A
Operating Margin
+4.7%
Net Margin
+9.3%
EPS Growth
+101.8%
Financial Health
Cash/Price Ratio
+193.4%
Current Ratio
1.1x
Debt/Equity
705.4x
ROE
+24.9%
ROA
+1.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Marex Group plc (MRX) Business Model
About Marex Group plc
What They Do
Global commodities broker specializing in diverse sectors.
Business Model
Marex Group plc operates as a global commodities broker, generating revenue through a variety of trading services in metals, agriculture, energy, and financial futures. The company assists institutional investors and commercial entities in managing risks and executing trades, thus earning fees from transactions and market-making activities.
Additional Information
Founded in 2005, Marex has built a strong reputation in the commodities trading market and utilizes advanced technology to enhance trading efficiency. The firm plays a crucial role in supporting price discovery and liquidity, while its significant international presence aids in facilitating global trade and promoting market transparency.
Company Information
Sector
Financial Services
Industry
Capital Markets
Employees
2,425
CEO
Mr. Ian Theo Lowitt
Country
United Kingdom
IPO Year
2024
Website
www.marex.comMarex Group plc (MRX) Latest News & Analysis
Latest News
Quick Summary
Investors are focusing on stocks with positive momentum, including ODD, CRS, HRTG, APH, and MRX.
Why It Matters
Stocks like ODD, CRS, HRTG, APH, and MRX showing bullish trends may indicate potential for gains, attracting investor interest and possibly driving up demand and prices.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Marex Group plc priced a public offering of $500 million in 5.829% Senior Notes due 2028, issued at 100% of principal, as senior unsecured obligations.
Why It Matters
Marex's $500 million bond offering at a 5.829% yield indicates strong capital raising efforts, impacting liquidity, debt levels, and potential returns for investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Financial Leader Marex Breaks Out To New Highs Amid Trump Tariff Volatility. Will Earnings Impress?
10 days ago
Quick Summary
Marex stock reached new highs after surpassing a buy point, with attention now on whether its first-quarter results will impress Wall Street.
Why It Matters
Marex's stock surge indicates strong market confidence and potential growth, making it a focal point for investors watching for positive earnings that could drive further gains.
Source: Investors Business Daily
Market Sentiment:
Positive
Fitch updates Marex's outlook to positive due to strong earnings and diversification of franchise
11 days ago
Quick Summary
Fitch Ratings revised Marex Group plc's Long-Term Issuer Default Rating outlook to positive from stable, affirming it at 'BBB-'. This reflects strong earnings, franchise expansion, and solid liquidity management.
Why It Matters
Fitch's positive outlook on Marex Group signals increased confidence in its financial stability and growth potential, which may attract investors seeking stable returns and opportunities for capital gains.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Marex Group plc (NASDAQ: MRX) will release its Q1 fiscal 2025 results on May 15, 2025, before market open. Details will be available on their investor website.
Why It Matters
Marex Group's upcoming Q1 earnings report could impact stock price and investor sentiment, providing insights into financial health and operational performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Loar and Marex are notable IPO stocks to watch this week, as they are rallying above their recent buy points amidst the current stock market activity.
Why It Matters
Loar and Marex's rally above buy points signals strong investor interest, indicating potential for growth, which may attract more capital and influence market trends.
Source: Investors Business Daily
Market Sentiment:
Positive
Frequently Asked Questions About MRX Stock
What is Marex Group plc's (MRX) stock forecast for 2025?
Based on our analysis of 9 Wall Street analysts, Marex Group plc (MRX) has a median price target of $44.50. The highest price target is $50.00 and the lowest is $36.00.
Is MRX stock a good investment in 2025?
According to current analyst ratings, MRX has 7 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $47.38. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MRX stock?
Wall Street analysts predict MRX stock could reach $44.50 in the next 12 months. This represents a -6.1% decrease from the current price of $47.38. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Marex Group plc's business model?
Marex Group plc operates as a global commodities broker, generating revenue through a variety of trading services in metals, agriculture, energy, and financial futures. The company assists institutional investors and commercial entities in managing risks and executing trades, thus earning fees from transactions and market-making activities.
What is the highest forecasted price for MRX Marex Group plc?
The highest price target for MRX is $50.00 from at , which represents a 5.5% increase from the current price of $47.38.
What is the lowest forecasted price for MRX Marex Group plc?
The lowest price target for MRX is $36.00 from Kyle Voigt at Keefe, Bruyette & Woods, which represents a -24.0% decrease from the current price of $47.38.
What is the overall MRX consensus from analysts for Marex Group plc?
The overall analyst consensus for MRX is bullish. Out of 9 Wall Street analysts, 7 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $44.50.
How accurate are MRX stock price projections?
Stock price projections, including those for Marex Group plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2025 3:46 PM UTC